Clinical Trial Update: Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 [NA]

View source ↗

Summary

A clinical trial evaluating Rg3 in combination with transarterial chemoembolization for hepatocellular carcinoma with high Notch1 expression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Rg3 (ginsenoside Rg3)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma, TACE | NA | Status: COMPLETED